These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

250 related articles for article (PubMed ID: 4180277)

  • 21. Experimental hematogenous pyelonephritis due to Escherichia coli in rabbits: the antibody response and its protective capacity.
    Kaijser B; Olling S
    J Infect Dis; 1973 Jul; 128(1):41-9. PubMed ID: 4577974
    [No Abstract]   [Full Text] [Related]  

  • 22. Immunobacteriological aspects of pyelonephritis.
    Miller TE; Stewart E; North JD
    Contrib Nephrol; 1979; 16():11-5. PubMed ID: 380894
    [No Abstract]   [Full Text] [Related]  

  • 23. [Production of O antigens and antibodies during urinary tract infections due to Escherichia coli (author's transl)].
    Fries D; Renault L; Mathieu D; Charpentier B; Guerin D; Jacques L
    Nouv Presse Med; 1979 Mar; 8(15):1239-43. PubMed ID: 375188
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Quantitative 99mTc-DMSA uptake in experimental pyelonephritis.
    Godley ML; Risdon RA; Gordon I; Parkhouse HF; Ransley PG
    J Nucl Med; 1999 Apr; 40(4):643-9. PubMed ID: 10210224
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Local immune response in experimental pyelonephritis in the rabbit. II. Lymphocyte stimulation by lipopolysaccharide of infecting organism.
    Smith JW
    Immunology; 1975 Dec; 29(6):1077-85. PubMed ID: 1104473
    [TBL] [Abstract][Full Text] [Related]  

  • 26. TH1 pattern of cytokine secretion by splenic cells from pyelonephritic mice after in-vitro stimulation with hsp-65 of Escherichia coli.
    Chopra U; Vohra H; Chhibber S; Ganguly NK; Sharma S
    J Med Microbiol; 1997 Feb; 46(2):139-44. PubMed ID: 9060873
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Significance of the number of pathogens in the development of antibody titer and experimental pyelonephritis].
    Loew H; Küster K; Ritzerfeld W
    Int J Clin Pharmacol; 1972 Aug; 6(3):276-84. PubMed ID: 4567538
    [No Abstract]   [Full Text] [Related]  

  • 28. Immunological enhancement in the pathogenesis of pyelonephritis.
    Miller TE; Burnham S; North JD
    Clin Exp Immunol; 1976 May; 24(2):336-45. PubMed ID: 776466
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The antibody response of children with pyelonephritis to different antigens of E. coli.
    Holmgren J; Eggertsen G; Hansson LA; Jodal U; Lincoln K; Winberg J
    Acta Pathol Microbiol Scand; 1968; 72(3):457. PubMed ID: 4967987
    [No Abstract]   [Full Text] [Related]  

  • 30. [Antibody response to P-fimbriae of Escherichia coli in patients with genitourinary infections].
    Kanai S; Miyake K; Agata N; Ohta M; Kato N
    Hinyokika Kiyo; 1990 Jan; 36(1):1-6. PubMed ID: 1968696
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Demonstration of E. coli-K-antigen in experimental pyelonephritis in guinea-pigs (author's transl)].
    Sietzen W; Klippel KF; Hauk H
    Med Microbiol Immunol; 1973 Sep; 159(1):101-3. PubMed ID: 4588886
    [No Abstract]   [Full Text] [Related]  

  • 32. [Serum antibodies in experimental E. coli infection of the kidneys and of the lower urinary tract].
    Prát V; Konícková L; Ritzerfeld W
    Cas Lek Cesk; 1969 Sep; 108(39):1153-6. PubMed ID: 4897607
    [No Abstract]   [Full Text] [Related]  

  • 33. Modification by suppressor cells and serum factors of the cell-mediated immune response in experimental pyelonephritis.
    Miller T; Scott L; Stewart E; North D
    J Clin Invest; 1978 Apr; 61(4):964-72. PubMed ID: 350900
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Immunization against retrograde pyelonephritis. II. Prevention of retrograde Escherichia coli pyelonephritis with vaccines.
    Brooks SJ; Lyons JM; Braude AI
    Am J Pathol; 1974 Feb; 74(2):359-64. PubMed ID: 4590646
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Local immune response in the kidneys of rabbits with nephrotoxic serum nephritis.
    Lehmann JD; Smith JW; Miller TE; Barnett JA; Sanford JP
    Br J Exp Pathol; 1969 Aug; 50(4):371-7. PubMed ID: 5806427
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Immunology of pyelonephritis in the primate model. II. Effect on immunosuppression.
    Roberts JA; Domingue GJ; Martin LN; Kim JC; Rangan SR
    Invest Urol; 1981 Nov; 19(3):148-53. PubMed ID: 6271703
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Precipitating antibodies to E. coli O antigens: a suggested difference in the antibody response of infants and children with first and recurrent attacks of pyelonephritis.
    Hanson LA; Holmgren J; Jodal U; Winberg J
    Acta Paediatr Scand; 1969 Sep; 58(5):506-12. PubMed ID: 4983439
    [No Abstract]   [Full Text] [Related]  

  • 38. Immunization against retrograde pyelonephritis. I. Production of an experimental model of severe ascending Escherichia coli pyelonephritis without bacteremia in rats.
    Brooks SJ; Lyons JM; Braude AI
    Am J Pathol; 1974 Feb; 74(2):345-58. PubMed ID: 4590645
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Immune response of the ileum to invasive Escherichia coli diarrheal disease in rabbits.
    O'Hanley PD; Cantey JR
    Infect Immun; 1981 Jan; 31(1):316-22. PubMed ID: 7011994
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A study of the intrarenal recycling of urea in the rat with chronic experimental pyelonephritis.
    Gilbert RM; Weber H; Turchin L; Fine LG; Bourgoignie JJ; Bricker NS
    J Clin Invest; 1976 Dec; 58(6):1348-57. PubMed ID: 993348
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.